Purchase Order 75F40126P00121
- Not listed
- The FDA's Office of Acquisition and Grants Services issued a purchase order to Digim Solution LLC on July 24, 2024, valued at $91,390.00 for image processing, modeling, and drug release simulation software (CDER-2024-123253-DM Image to Simulation). Digim Solution LLC is a minority-owned, woman-owned small business. Work is performed in Woburn, Massachusetts. The order covers image processing, modeling, and drug release simulation software capabilities. Ultimate completion is scheduled for...
- The Food and Drug Administration issued a $500,635 delivery order to Digim Solution LLC on September 1, 2026, for development and conduct of 3D correlative imaging, quantitative AI-based analysis of critical quality attributes, and image-based in silico release modeling using model long-acting drugs, inhalation products, and topical products. Digim Solution LLC is a minority-owned, woman-owned small business. Place of performance is Takoma Park, Maryland. The order is firm fixed price with an...
- The Food and Drug Administration awarded a $709,554 definitive contract to Digim Solution LLC for correlative 3D imaging and AI analysis to establish critical performance attributes of polymeric microsphere products on September 14, 2022. The award is firm fixed price with no set-aside. Place of performance is Lynn, MA. The work originated from an FDA Broad Agency Announcement posted November 10, 2021, seeking research and development proposals to advance regulatory science tools, standards, and...
- This is a task order awarded by the Food and Drug Administration (FDA) to Digim Solution LLC, a minority-owned small business, under an indefinite-delivery, indefinite-quantity (IDIQ) contract. The task order is for 3D microscopy, AI-based quantification, and modeling to support non-clinical evaluation and regulatory submissions for complex injectable and insertable drug products. The task order has a firm fixed price of $360,000.00 and a period of performance through March 9, 2026. Digim...
- This is a $250,000 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Digim Solution LLC, a minority-owned, for-profit, Asian-Pacific American business. The contract is for the development and conduct of 3D correlative imaging and quantitative artificial intelligence (AI)-based analysis of critical quality attributes (CQAs) for complex drug products. The contract does not have a set-aside designation. Digim Solution LLC has...
- <p>The Food and Drug Administration awarded a purchase order to Digim Solution LLC, a minority-owned woman-owned small business, for $210,000 on August 4, 2023, for advance product characterization and artificial intelligence analysis. Work is performed in Calverton, Maryland. The order carries firm fixed price terms and was extended through August 9, 2025, via no-cost modification. No set-aside designation applied to this procurement.</p>
- The Food and Drug Administration awarded a $151,889.44 firm fixed-price delivery order to Integration Technologies Group, Inc. (ITG), a Falls Church, Virginia-based small business, for the purchase of Decision Insight software to support PDUFA VI ESG metrics analysis. The contract, which was awarded on September 19, 2017, with an ultimate completion date of September 20, 2018, is designated as a total small business set-aside. The work will be performed in Silver Spring, Maryland, and is...
- This is a federal contract award issued by the Food and Drug Administration (FDA), a civilian agency, to Diamond Solutions, Inc., a small disadvantaged business, for a delivery order valued at $5,966,016.58. The contract is a time and materials type contract with a period of performance through September 29, 2017. The contract has no set-aside designation. Based on the information provided, this award appears to be part of the FDA's regular program work, though the specific products or...
- The Food and Drug Administration awarded a purchase order to Thinktrends, LLC for software support services valued at $161,530.03, effective September 16, 2025, with completion by September 28, 2026. Work is performed in Silver Spring, Maryland. The order supports the FDA's technology infrastructure on a firm fixed-price basis with no small business set-aside. The originating solicitation, posted July 22, 2025, sought an AI-based Optical Character Recognition solution to extract data from...
- The Food and Drug Administration issued a delivery order to Immersive Concepts LLC, an 8(a) certified, HUBZone-designated, minority-owned small business, on August 3, 2022, with a ceiling value of $470,322.27 and ultimate completion date of August 4, 2024. The order was issued under the FDA Logistics Systems IDIQ, a $4.5 million indefinite-delivery contract that expires July 2029. Performance took place in Silver Spring, MD. The work covered headquarters and field mail meter equipment...
The Food and Drug Administration awarded a purchase order to Digim Solution LLC for $111,390 on September 30, 2026 under a Total Small Business set-aside. The order procures image processing, modeling and simulation software, with performance at Silver Spring, Maryland. The contract type is Firm Fixed Price with an ultimate completion date of September 29, 2027. Digim Solution LLC is a minority-owned, Asian-Pacific American business based in Woburn, Massachusetts, specializing in advanced technological services for the pharmaceutical and regulatory sectors. The awardee holds an existing FDA indefinite delivery vehicle valued at $5 million through June 2029 for 3D microscopy, artificial intelligence-based quantification, and modeling supporting regulatory activities for complex drug products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $111.4k | 7/9/26 |